Security key
67644C104
Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA)
CUSIP: 67644C104
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 7,149,803
- Total 13F value
- $47,483,735
- Share change
- +7,149,803
- SEC-reported price per share
- $6.64
- Number of holders
- 16
- Value change
- +$47,483,735
- Number of buys
- 16
- Shares outstanding
- 39,127,596
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
16
Top holders
10
OCEA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Ocean Biomedical, Inc. SEC filings
Ocean Biomedical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67644C104
Recent filing periods:
Ownership snapshot
Top reported holders of OCEA - Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Aesther Healthcare Sponso...
Disclosed value leader
—
Comparable rows
0/9
Latest evidence
22 Mar 2023
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
9 rows are not safely comparable across share classes.
Showing 1-6 of 9 holder rows.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Aesther Healthcare Sponsor, LLC's linked filing trail.
Detailed SEC evidence table Showing 1-6 of 9 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Aesther Healthcare Sponsor, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
2,625,000 shares
|
— | 03 Nov 2021 |
| Surendra K. Ajjarapu |
3/4/5
Director
|
—
mixed-class rows
|
—
3,082,252 shares
mixed-class rows
|
— | 22 Mar 2023 |
| Michael L. Peterson |
3/4/5
Director
|
—
mixed-class rows
|
—
355,000 shares
mixed-class rows
|
— | 28 Feb 2023 |
| Jack A. Elias |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 15 Feb 2023 |
| Jerome Ringo |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 15 Feb 2023 |
| Jonathan D. Kurtis |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 15 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
7,149,803
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q2 2025 Across Filers
Q2 2025 holders
4
Q1 2023 holders
16
Holder diff
12
| Investor | Q2 2025 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q2 2025 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend